Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022104 (
irritable bowel syndrome
)
8,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Genome-Wide Association studies (GWAS) of both Crohn's Disease (CD) and Ulcerative Colitis (UC) have unearthed over 40 risk conferring variants. Recently, a meta-analysis on UC revealed several loci, most of which were either previously associated with UC or CD susceptibility in populations of European origin. In this study, we attempted to replicate these findings in an ethnically distinct north Indian UC cohort. 648 UC cases and 850 controls were genotyped using Infinium Human 660W-quad. Out of 59 meta-analysis index SNPs, six were not in the SNP array used in the study. Of the remaining 53 SNPs, four were found monomorphic. Association (p<0.05) at 25 SNPs was observed, of which 15 were CD specific. Only five SNPs namely rs2395185 (HLA-DRA), rs3024505 (IL10), rs6426833 (RNF186), rs3763313 (
BTNL2
) and rs2066843 (NOD2) retained significance after Bonferroni correction. These results (i) reveal limited replication of Caucasian based meta-analysis results; (ii) reiterate overlapping molecular mechanism(s) in UC and CD; (iii) indicate differences in genetic architecture between populations; and (iv) suggest that resources such as HapMap need to be extended to cover diverse ethnic populations. They also suggest a systematic GWAS in this terrain may be insightful for identifying population specific
IBD
risk conferring loci and thus enable cross-ethnicity fine mapping of disease loci.
...
PMID:An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians. 2130 77
The contribution of rare coding sequence variants to genetic susceptibility in complex disorders is an important but unresolved question. Most studies thus far have investigated a limited number of genes from regions which contain common disease associated variants. Here we investigate this in inflammatory bowel disease by sequencing the exons and proximal promoters of 531 genes selected from both genome-wide association studies and pathway analysis in pooled DNA panels from 474 cases of Crohn's disease and 480 controls. 80 variants with evidence of association in the sequencing experiment or with potential functional significance were selected for follow up genotyping in 6,507
IBD
cases and 3,064 population controls. The top 5 disease associated variants were genotyped in an extension panel of 3,662
IBD
cases and 3,639 controls, and tested for association in a combined analysis of 10,147
IBD
cases and 7,008 controls. A rare coding variant p.G454C in the
BTNL2
gene within the major histocompatibility complex was significantly associated with increased risk for
IBD
(p = 9.65x10-10, OR = 2.3[95% CI = 1.75-3.04]), but was independent of the known common associated CD and UC variants at this locus. Rare (<1%) and low frequency (1-5%) variants in 3 additional genes showed suggestive association (p<0.005) with either an increased risk (ARIH2 c.338-6C>T) or decreased risk (IL12B p.V298F, and NICN p.H191R) of
IBD
. These results provide additional insights into the involvement of the inhibition of T cell activation in the development of both sub-phenotypes of inflammatory bowel disease. We suggest that although rare coding variants may make a modest overall contribution to complex disease susceptibility, they can inform our understanding of the molecular pathways that contribute to pathogenesis.
...
PMID:Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes. 2588 32
Several Butyrophilin (BTN) and Btn-like (BTNL) molecules control T lymphocyte responses, and are genetically associated with inflammatory disorders and cancer. In this study, we present a comprehensive expression analysis of human and murine
BTN
and
BTNL
genes in conditions associated with intestinal inflammation and cancer. Using real-time PCR, expression of human
BTN
and
BTNL
genes was analyzed in samples from patients with ulcerative colitis,
irritable bowel syndrome
, and colon tumors. Expression of murine
Btn
and
Btnl
genes was examined in mouse models of spontaneous colitis (
Muc2
-/-
) and intestinal tumorigenesis (
Apc
Min/+
). Our analysis indicates a strong association of several of the human genes with ulcerative colitis and colon cancer; while especially
BTN1A1
,
BTN2A2
,
BTN3A3
, and
BTNL8
were significantly altered in inflammation, colonic tumors exhibited significantly decreased levels of
BTNL2
,
BTNL3
,
BTNL8
, and
BTNL9
as compared to unaffected tissue. Colonic inflammation in
Muc2
-/-
mice significantly down-regulated the expression of particularly
Btnl1
,
Btnl4
, and
Btnl6
mRNA, and intestinal polyps derived from
Apc
Min/+
mice displayed altered levels of
Btn1a1
,
Btn2a2
, and
Btnl1
transcripts. Thus, our data present an association of
BTN
and
BTNL
genes with intestinal inflammation and cancer and represent a valuable resource for further studies of this gene family.
...
PMID:Altered expression of Butyrophilin (
BTN
) and BTN-like (
BTNL
) genes in intestinal inflammation and colon cancer. 2795 27